Resource utilization and costs associated with achieved LDL-C levels in patients following a myocardial infarction treated with lipid-lowering therapies in Spain

Autor: C. Escobar Cervantes, J Lozano, F Sorio Vilela, A Sicras-Mainar, D.A Kahangire, I Campos Tapias

Publikováno v: European Heart Journal. 41

Background/Introduction Reduction in low-density lipoprotein cholesterol (LDL-C) significantly reduces cardiovascular (CV) risk, especially in patients with atherosclerotic CV disease. There is, however, a lack of evidence on the association between

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b54e85e04525d21c2dd9ae8189a9a4b
https://doi.org/10.1093/ehjci/ehaa946.3545

Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom

Autor: I Campos Tapias, G Worth, Maximilian H. M. Hatz, Ming-Hui Tai, H. Bailey, D. Catterick, Jason Shepherd

Publikováno v: Value in Health. 20:A627

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::837496d78a6c48baf612128c64cd872b
https://doi.org/10.1016/j.jval.2017.08.1385

The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone Metastases

Autor: Jindrich Finek, Petra Jandová, G Tritaki, F Gatta, DP Zahn, L Bolognese, R Ikenberg, J. Cristino, C Moser, M Perez Encinas, Guy Hechmati, N. Maniadakis, I Campos Tapias

Publikováno v: Value in Health. 18:A483

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b886503c4a5e973619c7f43d5fadf2
https://doi.org/10.1016/j.jval.2015.09.1317

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study.

Autor: Olmo-Montes FJ; Internal Medicine Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain., Caeiro-Rey JR; Traumatology Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Peris P; Rheumatology Department, Hospital Clinic de Barcelona, Barcelona, Spain., Pérez Del Río V; Traumatology Department, Hospital San Juan de la Cruz, Úbeda, Spain.; Medicine and Dermatology Department, Faculty of Medicine of Universidad de Málaga, Málaga, Spain., Etxebarria-Foronda Í; Traumatology Department, Hospital Alto Deba, Gipuzkoa, Spain., Cancio-Trujillo JM; Geriatrics Department, Badalona Serveis Assistencials, Badalona, Spain., Pareja T; Geriatrics Department, Hospital Universitario de Guadalajara, Guadalajara, Spain., Jódar E; Endocrinology Department, Hospital Universitario Quirón de Madrid, Madrid, Spain., Naranjo A; Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Moro-Álvarez MJ; Internal Medicine Department, Hospital Central Universitario Cruz Roja 'San Jose y Santa Adela', Madrid, Spain., García-Goñi M; Department of Applied & Structural Economics and History, Faculty of Economics and Business, Universidad Complutense de Madrid, Madrid, Spain., Vergés J; Asociación Española con la Osteoporosis y la Artrosis (AECOSAR), Madrid, Spain., Maratia S; UCB Pharma S.A., Madrid, Spain., Campos Tapias I; Amgen S.A., Barcelona, Spain., Prades M; Outcomes'10, S.L.U., Castellón de la Plana, Spain., Aceituno S; Outcomes'10, S.L.U., Castellón de la Plana, Spain.

Publikováno v: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2024 Dec 24; Vol. 16, pp. 889-901. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2024).